(Reuters) - The company said the approval was based on new clinical data demonstrating that the effects of the products may last for up to one year, which it said was longer than that of other hyaluronic acid dermal fillers.
Read more at Reuters.com Government Filings News
Read more at Reuters.com Government Filings News
No comments:
Post a Comment